TC
MRTX

TFS Capital’s Mirati Therapeutics, Inc. Common Stock MRTX Stock Holding History

TFS Capital’s Portfolio MRTX Stock Details MRTX Fund Activity
Upgrade to unlock
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
2017
Q1 		$64K Sell
2016
Q4 		$108K Buy
2016
Q3 		$70K Buy
2015
Q4 		– Sell
2015
Q3 		$1.05M Buy
2014
Q1 		– Sell
2013
Q4 		$291K Buy